<DOC>
	<DOC>NCT00569972</DOC>
	<brief_summary>To demonstrate efficacy and characterize the dose response relationship of PD 0200390 on subjective wake after sleep onset in subjects with primary insomnia.</brief_summary>
	<brief_title>A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<criteria>3 month history of primary insomnia; 18 to 64 years For the last 3 monthsregularly awake unrefreshed and unrestored Difficulty initiating and maintaining sleep for at least 3 nights/week for the past month (difficulty falling asleep, difficulty staying asleep, early awakening) Any history of an Axis 1 psychiatric diagnosis; History or presence of any breathing related sleep disorder; History or presence of any medical or neurological condition that could interfere with sleep Use of alcohol as a sleep aid or more than 2 standard drinks consumed per day or more than 14 consumed per week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>